BriefTea
Every story in sixty words
Health · 2 days ago
Marc Powell, who has a rare MND variant affecting fewer than 100 UK people, could die within a year while awaiting a treatment. Drug maker Biogen offers Tofersen free, but hospitals must cover administration costs, limiting patient numbers. The health watchdog NICE won't decide on NHS funding until next March, too late for many.
Reported by BBC · How we write briefs
More briefs
HealthCorrecting hearing loss can cut dementia risk by almost half HealthMan changes life after doctor warns liver disease could kill him HealthSweetener used in chewing gum and jam linked to strokes and heart attacks HealthMouth cancer rates up a third in UK, often with no obvious cause HealthBox breathing helps calm stress and reduce anxiety, say experts HealthNHS managers warn spiralling costs could disrupt ADHD and autism care More health stories → Browse all stories →